Total Payments
$23,223
2024 Payments
$714.84
Companies
27
Transactions
131
Medicare Patients
2,243
Medicare Billing
$219,320
Payment Breakdown by Category
Other$20,000 (86.1%)
Food & Beverage$2,686 (11.6%)
Travel$537.20 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $20,000 | 1 | 86.1% |
| Food and Beverage | $2,686 | 129 | 11.6% |
| Travel and Lodging | $537.20 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Medical LLC | $20,348 | 5 | $0 (2022) |
| Boston Scientific Corporation | $614.63 | 4 | $0 (2023) |
| ABBVIE INC. | $443.33 | 28 | $0 (2024) |
| Celgene Corporation | $379.75 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $215.38 | 11 | $0 (2024) |
| Gilead Sciences, Inc. | $166.33 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $134.32 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $117.27 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $116.07 | 5 | $0 (2024) |
| Ardelyx, Inc. | $107.99 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $714.84 | 35 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($101.99) |
| 2023 | $588.73 | 32 | Celgene Corporation ($175.35) |
| 2022 | $456.33 | 21 | ABBVIE INC. ($137.25) |
| 2021 | $303.16 | 19 | AbbVie Inc. ($153.64) |
| 2020 | $184.33 | 6 | Cook Medical LLC ($98.92) |
| 2019 | $386.37 | 14 | Cook Medical LLC ($175.59) |
| 2018 | $20,590 | 4 | Cook Medical LLC ($20,000) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.48 | General |
| 11/08/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: GI COLON PREP | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
| 11/04/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: GI | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.16 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Immunology | ||||||
| 09/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.55 | General |
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Gastroenterology | ||||||
| 08/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Gastroenterology | ||||||
| 06/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: Neuroscience | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.05 | General |
| 05/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 560 | 585 | $381,328 | $53,723 |
| 2022 | 16 | 544 | 568 | $362,166 | $53,193 |
| 2021 | 15 | 633 | 659 | $438,455 | $64,606 |
| 2020 | 15 | 506 | 522 | $308,617 | $47,798 |
Total Patients
2,243
Total Services
2,334
Medicare Billing
$219,320
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 99 | 101 | $110,999 | $20,852 | 18.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 39 | $25,779 | $5,542 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $10,710 | $3,935 | 36.7% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $14,800 | $2,995 | 20.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 94 | 95 | $66,690 | $2,935 | 4.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $14,112 | $2,668 | 18.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 27 | 34 | $15,844 | $2,644 | 16.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 17 | 19 | $24,548 | $2,389 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 27 | $6,237 | $2,378 | 38.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $8,624 | $1,843 | 21.4% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 15 | 15 | $8,385 | $1,826 | 21.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,576 | $1,152 | 32.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 25 | 26 | $25,272 | $1,081 | 4.3% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 39 | 40 | $38,760 | $687.60 | 1.8% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 14 | 18 | $2,502 | $335.16 | 13.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 69 | 71 | $3,905 | $331.19 | 8.5% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 13 | 13 | $585.00 | $128.25 | 21.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 110 | 111 | $121,989 | $21,515 | 17.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 33 | 40 | $18,640 | $3,809 | 20.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 93 | 96 | $67,392 | $3,784 | 5.6% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $15,864 | $3,426 | 21.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 21 | $9,198 | $3,352 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,854 | $2,906 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 30 | $6,930 | $2,716 | 39.2% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $12,025 | $2,558 | 21.3% |
About Dr. Taimur Khan, M.D
Dr. Taimur Khan, M.D is a Gastroenterology healthcare provider based in Lakewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1235387358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taimur Khan, M.D has received a total of $23,223 in payments from pharmaceutical and medical device companies, with $714.84 received in 2024. These payments were reported across 131 transactions from 27 companies. The most common payment nature is "Grant" ($20,000).
As a Medicare-enrolled provider, Khan has provided services to 2,243 Medicare beneficiaries, totaling 2,334 services with total Medicare billing of $219,320. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lakewood, CO
- Active Since 09/03/2008
- Last Updated 04/17/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1235387358
Products in Payments
- ACQUIRE (Device) $575.60
- ZEPOSIA (Drug) $379.75
- DUPIXENT (Biological) $185.99
- MAVYRET (Drug) $151.89
- XIFAXAN (Drug) $142.80
- HUMIRA (Biological) $115.16
- IBSRELA (Drug) $107.99
- XELJANZ (Drug) $103.16
- Cook Medical Plastic Stents (Device) $98.92
- Cook Medical Hemospray (Device) $95.91
- Cook Medical Biliary (Device) $79.68
- INSTINCT (Device) $73.45
- TRULANCE (Drug) $72.58
- REMICADE (Biological) $68.38
- CREON (Drug) $63.25
- ENTYVIO (Biological) $60.35
- LINZESS (Drug) $59.69
- OMVOH (Drug) $50.89
- STELARA (Biological) $45.87
- DIFICID (Drug) $43.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lakewood
Rajesh Jain, M.d, M.D
Gastroenterology — Payments: $148,077
Gastroenterology $148,077
John Goff, M.d, M.D
Gastroenterology — Payments: $65,770
Gastroenterology $65,770
Conrad Cox, M.d, M.D
Gastroenterology — Payments: $37,352
Gastroenterology $37,352
Dr. Matthew Seto, D.o, D.O
Gastroenterology — Payments: $11,976
Gastroenterology $11,976
Scott Mackenzie, Md, MD
Gastroenterology — Payments: $11,896
Gastroenterology $11,896
Dr. Andrew Korson, M.d, M.D
Gastroenterology — Payments: $10,583
Gastroenterology $10,583